juvenile idiopathic arthritis
ACR Updates 2 Juvenile Idiopathic Arthritis Treatment Guidelines
The ACR released new updated guidelines on the pharmacologic and nonpharmacologic treatment of juvenile ...
MARCH 18, 2022
FDA Approves Biosimilar for Multiple Rheumatologic Conditions
The FDA approved adalimumab-bwwd, a biosimilar referencing adalimumab, for the treatment of rheumatoid arthritis, ...
AUGUST 28, 2019
Load more